Acciones Goodbody Health Canadian Securities Exchange
Acciones
SWEL
CA3821591011
Farmacéuticos
Ventas 2020 | 1,99 M 2,49 M 3,41 M 2,33 M | Ventas 2021 | 17,06 M 21,31 M 29,13 M 19,92 M | Capitalización | 13,76 M 17,19 M 23,49 M 16,07 M |
---|---|---|---|---|---|
Resultado Neto 2020 | -4 M -5 M -6,83 M -4,67 M | Resultado Neto 2021 | -2 M -2,5 M -3,42 M -2,34 M | VE / Ventas 2020 | 5,41 x |
Posición de caja neta 2020 | 1,37 M 1,72 M 2,34 M 1,6 M | Posición de caja neta 2021 | 5,73 M 7,16 M 9,79 M 6,69 M | VE / Ventas 2021 | 0,47 x |
P/E ratio 2020 |
-1,4
x | P/E ratio 2021 |
-5,64
x | Empleados | - |
Rendimiento 2020 * |
-
| Rendimiento 2021 |
-
| Flotante | 70,26 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 26/01/21 |
Geremy Thomas
FOU | Founder | 64 | 14/02/11 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 14/02/11 |
George Thomas
CEO | Chief Executive Officer | 35 | 26/01/21 |
Anne Tew
SEC | Corporate Secretary | - | 01/11/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+35,04 % | 5918,64 M | |
-15,13 % | 4514,3 M | |
-9,75 % | 3154,5 M | |
+2,14 % | 3104,29 M | |
-6,82 % | 2419,24 M | |
+47,87 % | 1968,91 M | |
-7,89 % | 1679,28 M | |
+0,09 % | 1646,92 M | |
-12,97 % | 1529,77 M |